Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹56 Cr
Revenue (TTM)
₹51 Cr
Net Profit (TTM)
₹5 Cr
ROE
11.7 %
ROCE
12.6 %
P/E Ratio
12.5
P/B Ratio
0.6
Industry P/E
357.65
EV/EBITDA
5.1
Div. Yield
0 %
Debt to Equity
0.8
Book Value
₹43.5
EPS
₹2.2
Face value
10
Shares outstanding
22,190,628
CFO
₹95.10 Cr
EBITDA
₹141.74 Cr
Net Profit
₹33.56 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vivo Bio Tech
| -22.0 | -11.7 | -12.6 | -32.6 | 2.6 | -14.4 | -5.0 |
|
BSE Healthcare
| -3.4 | -3.2 | -3.5 | 3.6 | 24.9 | 15.6 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Vivo Bio Tech
| -15.4 | 9.0 | 11.8 | -57.0 | 23.3 | 89.3 | -60.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vivo Bio Tech
|
24.7 | 56.3 | 51.4 | 4.5 | 22.0 | 5.2 | 12.5 | 0.6 |
| 165.1 | 2,627.7 | 2,796.8 | 118.8 | 8.1 | 2.3 | 22.1 | 0.4 | |
| 28.4 | 8.7 | 0.5 | 0.0 | 8.3 | -1.1 | -- | 2.2 | |
| 450.7 | 10,732.6 | 3,262.7 | 439.0 | 15.3 | 16 | 24.4 | 3.6 | |
| 53.0 | 190.1 | 133.8 | -0.3 | -0.7 | -0.6 | -- | 1.9 | |
| 163.6 | 7,497.6 | 2,803.3 | 361.8 | 15.5 | 14 | 20.8 | 2.7 | |
| 1,012.5 | 21,325.1 | 2,169.9 | 332.9 | 20.9 | 15.4 | 64.1 | 9.0 | |
| 4,235.0 | 9,706.6 | 878.4 | 240.1 | 33.8 | 73.3 | 40.4 | 25.3 | |
| 38.1 | 564.1 | 0.0 | 1.6 | -- | -0.5 | 350.6 | 21.0 |
No Review & Analysis are available.
Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vitro, in vivo, toxicity studies, pharmacological investigations, pharmacokinetic... and toxico kinetic studies, genotoxicity screening, analytical services, etc. It also supplies SPF lab animals. The company was formerly known as Sunshine Factors & Exports Limited and changed its name to Vivo Bio Tech Limited in September 2002. Vivo Bio Tech Limited was incorporated in 1987 and is based in Hyderabad, India. Read more
Incorporated
1987
Chairman
--
Managing Director
--
Headquarters
Hyderabad, Telangana
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Vivo Bio Tech Ltd is ₹24.65 (BSE) as of 19-Mar-2026 12:58 IST. Vivo Bio Tech Ltd has given a return of 2.6% in the last 3 years.
The P/E ratio of Vivo Bio Tech Ltd is 12.47 times as on 19-Mar-2026, a 97 discount to its peers’ median range of 357.65 times.
The P/B ratio of Vivo Bio Tech Ltd is 0.58 times as on 19-Mar-2026, a 70 discount to its peers’ median range of 1.92 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
8.01
|
0.83
|
|
2024
|
25.29
|
1.18
|
|
2023
|
10.86
|
0.56
|
|
2022
|
25.69
|
1.23
|
|
2021
|
11.31
|
1.57
|
The 52-week high and low of Vivo Bio Tech Ltd are Rs 44.70 and Rs 22.90 as of 19-Mar-2026.
Vivo Bio Tech Ltd has a market capitalisation of ₹ 56 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Vivo Bio Tech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.49
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.